Bertolet, Barry D. https://orcid.org/0000-0003-4502-7074
Cabral, Katherine P.
Sullenberger, Lance
McAlister, Jan L.
Sandroni, Todd
Patel, Dharmesh S.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Accepted: 2 July 2024
First Online: 13 August 2024
Declarations
:
: Medical writing support was funded by Novartis Pharmaceuticals Corporation.
: B.D.B. has received speaker honoraria from Amgen, AstraZeneca, Novartis, and Shockwave Medical and has served as a consultant to Medtronic. K.P.C. has received speaker honoraria from Bristol Myers Squibb. L.S. has received speaker honoraria from Novartis. J.L.M. has served as a consultant for Amgen and Novartis and has received speaker honoraria from Amgen. T.S. has nothing to disclose. D.S.P. has received consulting fees and speaker honoraria from Amgen and Johnson & Johnson Innovative Medicine, and has received speaker honoraria from AstraZeneca, Boehringer Ingelheim, and Esperion.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All the listed authors contributed to the work. All authors drafted or substantially revised this manuscript as per their clinical expertise and experience. Authors made the final decision on all aspects of this publication and approved the final version.